Corteva (NYSE:CTVA) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says

Corteva (NYSE:CTVA) had its price objective lifted by Jefferies Financial Group from $85.00 to $95.00 in a research report issued on Monday,MarketScreener reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group’s target price indicates a potential upside of 20.50% from the company’s current price.

A number of other research firms also recently issued reports on CTVA. UBS Group cut Corteva from a “buy” rating to a “hold” rating in a research note on Monday, February 9th. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 target price on shares of Corteva in a research report on Thursday, February 5th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Corteva from $85.00 to $90.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Finally, Rothschild & Co Redburn lowered their target price on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a report on Tuesday, November 11th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $82.80.

Corteva Stock Performance

Shares of CTVA opened at $78.84 on Monday. The company has a market cap of $53.02 billion, a price-to-earnings ratio of 49.90, a P/E/G ratio of 2.75 and a beta of 0.72. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva has a 12 month low of $53.40 and a 12 month high of $80.90. The business’s fifty day simple moving average is $72.42 and its two-hundred day simple moving average is $68.91.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter in the prior year, the business earned $0.32 earnings per share. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva will post 2.96 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.15% of the company’s stock.

Hedge Funds Weigh In On Corteva

Several institutional investors have recently made changes to their positions in CTVA. Brighton Jones LLC raised its position in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the last quarter. Woodline Partners LP raised its holdings in shares of Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after acquiring an additional 16,644 shares during the last quarter. Y Intercept Hong Kong Ltd lifted its position in shares of Corteva by 40.5% in the second quarter. Y Intercept Hong Kong Ltd now owns 18,463 shares of the company’s stock valued at $1,376,000 after acquiring an additional 5,326 shares in the last quarter. World Investment Advisors boosted its stake in shares of Corteva by 21.8% in the second quarter. World Investment Advisors now owns 8,994 shares of the company’s stock worth $670,000 after acquiring an additional 1,608 shares during the last quarter. Finally, Arkadios Wealth Advisors increased its position in shares of Corteva by 31.4% during the second quarter. Arkadios Wealth Advisors now owns 13,162 shares of the company’s stock worth $981,000 after purchasing an additional 3,148 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.